Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition

American Journal of Transplantation

Volumn 9, Issue 4, 2009, Pages 727-733

  Hodge, S ^a   Holmes, M ^a,b   Banerjee, B ^c,d   Musk, M ^c   Kicic, A ^e   Waterer, G ^d   Reynolds, P N ^a   Hodge, G ^a   Chambers, D C ^d,f  

^a HANSON INSTITUTE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Bronchiolitis obliterans syndrome; Epithelial mesenchymal transition; Flow cytometry; Lung transplantation; Obilterative bronchiolitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; ECTODYSPLASIN A; HLA DR ANTIGEN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AIRWAY; ALLOGRAFT; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE; MESENCHYME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD45; BRONCHI; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LUNG TRANSPLANTATION; MALE; MESODERM; MIDDLE AGED; RISK ASSESSMENT; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 63349086347     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02558.x     Document Type: Article

References (20)

1. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007 26 : 681 686.
2. Boehler A, Estenne M. Posttransplant bronchiolitis obliterans. Eur Respir J 2003 22 : 1007 1018.
3. Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 : 782 795.
4. Palmer SM, Davis RD, Hadjiliadis D et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002 74 : 799 804.
5. Reznik SI, Jaramillo A, SivaSai KS et al. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001 1 : 228 235.
6. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003 112 : 1776 1784.
7. Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006 3 : 377 382.
8. Serini G, Bochaton-Piallat ML, Ropraz P et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998 142 : 873 881.
9. Willis BC, Borok Z. TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol 2007 293 : L525 L534.
10. Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005 16 : 68 78.
11. El-Gamel A, Sim E, Hasleton P et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999 18 : 828 837.
12. Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297 310.
13. Hodge SJ, Hodge GL, Reynolds PN, Holmes MD. Differential rates of apoptosis in bronchoalveolar lavage and blood of lung transplant patients. J Heart Lung Transplant 2005 24 : 1305 1314.
14. Hodge S, Hodge G, Holmes M, Reynolds PN. Flow-cytometric characterisation of cell populations in bronchoalveolar lavage (BAL) and bronchial brushings from patients with chronic obstructive pulmonary disease (COPD). Cytometry 2004 61B : 27 34.
15. Ward C, Effros RM, Walters EH. Assessment of epithelial lining fluid dilution during bronchoalveolar lavage. Eur Respir Rev 1999 9 : 32 37.
16. Ward C, Forrest IA, Murphy DM et al. The phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005 60 : 865 871.
17. Mamessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M. T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 2007 84 : 908 916.
18. Myerburg MM, Latoche JD, McKenna EE et al. Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells. Am J Physiol 2007 292 : L1352 L1360.
19. Aharinejad S, Taghavi S, Klepetko W, Abraham D. Prediction of lung-transplant rejection by hepatocyte growth factor. Lancet 2004 363 : 1503 1508.
20. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002 13 : 96 107.